| BRENSOCATIB | None | ||
| 10MG, 25MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| BRINSUPRI is a dipeptidyl peptidase 1 (DPP1) inhibitor indicated for the treatment of non-cystic fibrosis bronchiectasis in adult and pediatric patients 12 years of age and older. | |||
|
Yes
| |||
| BRINSUPRI | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(* *)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ******* (**)-*-[(**)-*-*****-*-***********]-*,*-*********-*-************ ** ********** ********* * ********** | ************** ************ ********** (**)-*-{(**)-*-*****-*-[*-(*-******-*-***-*,*-*******-*,*-**********-*-**)******]*****}-*,*-*********-*-*********** | ************** ************ ********** (**)-*-{(**)-*-*****-*-[*-(*-******-*-***-*,*-*******-*,*-**********-*-**)******]*****}-*,*-*********-*-*********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|